Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Cash flow from operating activities:    
Net loss $ (49,215) $ (46,842)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 5,502 3,451
Bad debt expense 1,484 (226)
Stock-based compensation expense, net of amounts capitalized 28,711 25,532
Non-cash interest paid in kind and discount amortization 0 3,267
Noncash lease expense 3,002  
Deferred income taxes 0 1
Other noncash items, net 577 (999)
Changes in operating assets and liabilities:    
Accounts receivable 18,452 11,810
Prepaid expenses and other current assets 14,245 1,088
Other noncurrent assets (393) (7,668)
Accounts payable 22,618 (6,751)
Operating lease right-of-use assets (3,730)  
Accrued expenses and other current liabilities (18,714) (2,326)
Litigation settlement (12,000) 0
Deferred revenue (6,280) 2,956
Other liabilities (1,285) (154)
Net cash provided by (used in) operating activities 2,974 (16,861)
Cash flow from investing activities:    
Purchases of marketable securities (448,083) (61,758)
Sales of marketable securities 2,838 56,652
Maturities of marketable securities 267,699 101,860
Purchases of property and equipment (2,352) (3,862)
Capitalized internal-use software (5,016) (2,481)
Net cash (used in) provided by investing activities (184,915) 90,411
Cash flow from financing activities:    
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 276,001
Proceeds from issuance of common stock upon exercise of stock options 10,429 16,659
Proceeds from issuance of common stock upon ESPP purchases 6,213 0
Net cash provided by financing activities 16,642 292,660
Effect of exchange rate fluctuations on cash and cash equivalents (1,919) (257)
Net change in cash and cash equivalents (167,218) 365,953
Cash and cash equivalents at beginning of period 321,426 68,037
Cash and cash equivalents at end of period 154,208 433,990
Supplemental disclosure of cash flow information    
Cash paid for income taxes 2,885 1,564
Supplemental disclosure for noncash investing and financing    
Stock-based compensation expense capitalized in internal-use software 875 233
Accrued purchases of property and equipment 1,375 $ 498
Right of use assets obtained in exchange for operating lease liabilities $ 2,763